We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Celadon Pharmaceuticals Plc | LSE:CEL | London | Ordinary Share | GB00BDQYGP38 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
1.50 | 2.52% | 61.00 | 57.00 | 65.00 | 61.00 | 59.50 | 59.50 | 12,246 | 14:00:11 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Investment Advice | 149k | -7.14M | -0.1082 | -5.64 | 39.26M |
TIDMCELFORM 8.3
DEALINGS BY PERSONS WITH INTERESTS IN SECURITIES REPRESENTING 1% OR MORE
(Rule 8.3 of the Takeover Code)
1.KEY INFORMATION
Name of person dealing(Note 1) Arnhold and S. Bleichroeder Advisers, LLC =------------------------------------------------------------------------- Company dealt in Celsis International Plc =------------------------------------------------------------------------- Class of relevant security to 5p ordinary shares which the dealings being disclosed relate (Note 2) =------------------------------------------------------------------------- Date of dealing August 26, 2009 =-------------------------------------------------------------------------2.INTERESTS, SHORT POSITIONS AND RIGHTS TO SUBSCRIBE
(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)
Long Short =----------------------------------------------------------------- Number (%) Number (%) =----------------------------------------------------------------- (1) Relevant securities =----------------------------------------------------------------- (2) Derivatives (other than options) 525,000 2.40% =----------------------------------------------------------------- (3) Options and agreements to purchase/sell =----------------------------------------------------------------- Total 525,000 2.40% =-----------------------------------------------------------------(b)Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)
Class of relevant security: Long Short =--------------------------------------------------------------------- Number (%) Number (%) =--------------------------------------------------------------------- (1) Relevant securities =--------------------------------------------------------------------- (2) Derivatives (other than options) =--------------------------------------------------------------------- (3) Options and agreements to purchase/sell =--------------------------------------------------------------------- Total =---------------------------------------------------------------------(c)Rights to subscribe (Note 3)
Class of relevant security: Details =------------------------------------ =------------------------------------3.DEALINGS (Note 4)
(a)Purchases and sales
Purchase/sale Number of securities Price per unit(Note 5) =----------------------------------------------------------- =-----------------------------------------------------------(b)Derivatives transactions (other than options)
Product name, Long/short(Note 6) Number Price per unit(Note e.g. CFD of securities(Note 5) 7) =-------------------------------------------------------------------------- CFD Long 50,000 GBP 2.328488 =--------------------------------------------------------------------------(c)Options transactions in respect of existing securities
(i)Writing, selling, purchasing or varying
Product Writing, Number of Exercise Type, Expiry Option name, selling, securities price e.g. Date money e.g. call purchasing, to American, paid/received option varying etc. which the European per unit option etc. (Note 5) relates (Note 7) =------------------------------------------------------------------------------- =-------------------------------------------------------------------------------(ii)Exercising
Product name, e.g. call option Number of securities Exercise price per unit(Note 5) =------------------------------------------------------------------------ =------------------------------------------------------------------------(d)Other dealings (including new securities) (Note 4)
Nature of transaction(Note 8) Details Price per unit (if applicable)(Note 5) =----------------------------------------------------------- =-----------------------------------------------------------4.OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated. =----------------------------------------------------------- None. =-----------------------------------------------------------Is a Supplemental Form 8 attached? (Note 9) YES/NO
Date of disclosure August 26, 2009 =------------------------------------------------------------------------ Contact name W. Rubenstein =------------------------------------------------------------------------ Telephone number (212) 698-3128 =------------------------------------------------------------------------ If a connected EFM, name of offeree/offeror with which connected =------------------------------------------------------------------------ If a connected EFM, state nature of connection(Note 10) =------------------------------------------------------------------------Notes
The Notes on Form 8.3 can be viewed on the Takeover Panel's website at www.thetakeoverpanel.org.uk
1 Year Celadon Pharmaceuticals Chart |
1 Month Celadon Pharmaceuticals Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions